Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic development.

Dahiya S, Nonnemacher MR, Wigdahl B.

J Gen Virol. 2012 Jun;93(Pt 6):1151-72. doi: 10.1099/vir.0.041186-0. Epub 2012 Mar 14.

PMID:
22422068
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The HIV1 protein Vpr acts to enhance constitutive DCAF1-dependent UNG2 turnover.

Wen X, Casey Klockow L, Nekorchuk M, Sharifi HJ, de Noronha CM.

PLoS One. 2012;7(1):e30939. doi: 10.1371/journal.pone.0030939. Epub 2012 Jan 24.

PMID:
22292079
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The natural killer cell cytotoxic function is modulated by HIV-1 accessory proteins.

Sowrirajan B, Barker E.

Viruses. 2011 Jul;3(7):1091-111. doi: 10.3390/v3071091. Epub 2011 Jul 8. Review.

PMID:
21994772
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Delineating HIV-associated neurocognitive disorders using transgenic models: the neuropathogenic actions of Vpr.

Power C, Hui E, Vivithanaporn P, Acharjee S, Polyak M.

J Neuroimmune Pharmacol. 2012 Jun;7(2):319-31. doi: 10.1007/s11481-011-9310-7. Epub 2011 Sep 15. Review.

PMID:
21918813
[PubMed - indexed for MEDLINE]
5.

Molecular insight into how HIV-1 Vpr protein impairs cell growth through two genetically distinct pathways.

Maudet C, Bertrand M, Le Rouzic E, Lahouassa H, Ayinde D, Nisole S, Goujon C, Cimarelli A, Margottin-Goguet F, Transy C.

J Biol Chem. 2011 Jul 8;286(27):23742-52. doi: 10.1074/jbc.M111.220780. Epub 2011 May 12.

PMID:
21566118
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention.

Kogan M, Rappaport J.

Retrovirology. 2011 Apr 13;8:25. doi: 10.1186/1742-4690-8-25. Review.

PMID:
21489275
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Vpr-host interactions during HIV-1 viral life cycle.

Zhao RY, Li G, Bukrinsky MI.

J Neuroimmune Pharmacol. 2011 Jun;6(2):216-29. doi: 10.1007/s11481-011-9261-z. Epub 2011 Feb 12. Review.

PMID:
21318276
[PubMed - indexed for MEDLINE]
8.

Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?

Ayinde D, Maudet C, Transy C, Margottin-Goguet F.

Retrovirology. 2010 Apr 9;7:35. doi: 10.1186/1742-4690-7-35. Review.

PMID:
20380700
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The functions of the HIV1 protein Vpr and its action through the DCAF1.DDB1.Cullin4 ubiquitin ligase.

Casey L, Wen X, de Noronha CM.

Cytokine. 2010 Jul;51(1):1-9. doi: 10.1016/j.cyto.2010.02.018. Epub 2010 Mar 27. Review.

PMID:
20347598
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Multifaceted activity of HIV Vpr/Vpx proteins: the current view of their virological functions.

Fujita M, Otsuka M, Nomaguchi M, Adachi A.

Rev Med Virol. 2010 Mar;20(2):68-76. doi: 10.1002/rmv.636. Review.

PMID:
20069611
[PubMed - indexed for MEDLINE]
11.

Vpr and its interactions with cellular proteins.

Planelles V, Benichou S.

Curr Top Microbiol Immunol. 2009;339:177-200. doi: 10.1007/978-3-642-02175-6_9. Review.

PMID:
20012529
[PubMed - indexed for MEDLINE]
12.

HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase.

Transy C, Margottin-Goguet F.

Cell Cycle. 2009 Aug 15;8(16):2489-90. No abstract available.

PMID:
19667756
[PubMed - indexed for MEDLINE]
Free Article
13.

Human immunodeficiency virus type 1 Vpr: functions and molecular interactions.

Romani B, Engelbrecht S.

J Gen Virol. 2009 Aug;90(Pt 8):1795-805. doi: 10.1099/vir.0.011726-0. Epub 2009 May 20. Review.

PMID:
19458171
[PubMed - indexed for MEDLINE]
Free Article
14.

Structure-function relationship of Vpr: biological implications.

Morellet N, Roques BP, Bouaziz S.

Curr HIV Res. 2009 Mar;7(2):184-210. Review.

PMID:
19275588
[PubMed - indexed for MEDLINE]
15.

HIV-1 Vpr: a novel role in regulating RNA splicing.

Zhang X, Aida Y.

Curr HIV Res. 2009 Mar;7(2):163-8. Review.

PMID:
19275585
[PubMed - indexed for MEDLINE]
16.

Vpr-induced DNA double-strand breaks: molecular mechanism and biological relevance.

Nakai-Murakami C, Minemoto Y, Ishizaka Y.

Curr HIV Res. 2009 Mar;7(2):109-13. Review.

PMID:
19275579
[PubMed - indexed for MEDLINE]
17.

Human immunodeficiency virus type 1 Vpr-binding protein VprBP, a WD40 protein associated with the DDB1-CUL4 E3 ubiquitin ligase, is essential for DNA replication and embryonic development.

McCall CM, Miliani de Marval PL, Chastain PD 2nd, Jackson SC, He YJ, Kotake Y, Cook JG, Xiong Y.

Mol Cell Biol. 2008 Sep;28(18):5621-33. doi: 10.1128/MCB.00232-08. Epub 2008 Jul 7.

PMID:
18606781
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

HIV-1 accessory proteins--ensuring viral survival in a hostile environment.

Malim MH, Emerman M.

Cell Host Microbe. 2008 Jun 12;3(6):388-98. doi: 10.1016/j.chom.2008.04.008. Review.

PMID:
18541215
[PubMed - indexed for MEDLINE]
Free Article
19.

HIV-1 Vpr: mechanisms of G2 arrest and apoptosis.

Andersen JL, Le Rouzic E, Planelles V.

Exp Mol Pathol. 2008 Aug;85(1):2-10. doi: 10.1016/j.yexmp.2008.03.015. Epub 2008 Apr 25. Review.

PMID:
18514189
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation.

Dehart JL, Planelles V.

J Virol. 2008 Feb;82(3):1066-72. Epub 2007 Sep 12. Review. No abstract available.

PMID:
17855541
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk